DAMGO

(1E,2S)-2-Amino-N-[(1Z,2R)-1-hydroxy-1-({2-[{(1Z,2S)-1-hydroxy-1-[(2-hydroxyethyl)imino]-3-phenyl-2-propanyl}(methyl)amino]-2-oxoethyl}imino)-2-propanyl]-3-(4-hydroxyphenyl)propanimidic acid

(1E,2S)-2-Amino-N-[(1Z,2R)-1-hydroxy-1-({2-[{(1Z,2S)-1-hydroxy-1-[(2-hydroxyethyl)imino]-3-phenyl-2-propanyl}(methyl)amino]-2-oxoethyl}imino)-2-propanyl]-3-(4-hydroxyphenyl)propanimidsäure

(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]-methylamino]-N-(2-hydroxyethyl)-3-phenylpropanamide

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]-N-methylacetamido}-N-(2-hydroxyethyl)-3-phenylpropanamide

(Z,2S)-2-{2-[(Z)-[(2R)-2-[(Z)-[(2S)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino]-1-hydroxypropylidene]amino]-N-methylacetamido}-N-(2-hydroxyethyl)-3-phenylpropanimidic acid

78123-71-4

[D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin

[tyrosyl-3,5-3H(N)] D-Ala2-Mephe4-glyol5-enkephalin

Acide (1E,2S)-2-amino-N-[(1Z,2R)-1-hydroxy-1-({2-[{(1Z,2S)-1-hydroxy-1-[(2-hydroxyéthyl)imino]-3-phényl-2-propanyl}(méthyl)amino]-2-oxoéthyl}imino)-2-propanyl]-3-(4-hydroxyphényl)propanimidique

Ala(2)-MePhe(4)-Gly-ol(5) Enkephalin

Benzenepropanimidic acid, alpha-amino-4-hydroxy-N-[(1R,2Z)-2-hydroxy-2-[[2-[[(1S,2Z)-2-hydroxy-2-[(2-hydroxyethyl)imino]-1-(phenylmethyl)ethyl]methylamino]-2-oxoethyl]imino]-1-methylethyl]-, (alphaS)-

DAMGO

[Wiki]

Enkephalin, Ala(2)-MePhe(4)-Gly(5)-

Enkephalin, Ala(2)-MePhe(4)-Gly-ol(5)-

Enkephalin, alanyl(2)-methylphenylalanyl(4)-glycine(5)-

L-Phenylalaninamide, L-tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-Nalpha-methyl-

L-Tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-Nalpha-methyl-L-phenylalaninamid

L-Tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-Nalpha-methyl-L-phenylalaninamide

L-Tyrosyl-D-alanylglycyl-N-(2-hydroxyéthyl)-Nalpha-méthyl-L-phénylalaninamide

Tyr-D-Ala-Gly-MePhe-Gly-ol

Tyr-D-Ala-Gly-N-Methyl-Phe-Gly-ol

(2S)-2-amino-N-[(2R)-1-[[2-[[(2S)-1-(2-hydroxyethylamino)-1-oxo-3-phenylpropan-2-yl]-methylamino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide

(D-Ala(2)-mephe(4)-gly-ol(5))enkephalin

(S)-2-amino-N-((R)-1-((2-(((S)-1-((2-hydroxyethyl)amino)-1-oxo-3-phenylpropan-2-yl)(methyl)amino)-2-oxoethyl)amino)-1-oxopropan-2-yl)-3-(4-hydroxyphenyl)propanamide

(S)-2-amino-N-{(R)-1-[({[(S)-1-(2-hydroxy-ethylcarbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl}-methyl)-carbamoyl]-ethyl}-3-(4-hydroxy-phenyl)-propionamide

(S)-2-Amino-N-{1-[({[(S)-1-(2-hydroxy-ethylcarbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl}-methyl)-carbamoyl]-ethyl}-3-(4-hydroxy-phenyl)-propionamide

(S)-2-Amino-N-{1-[({[1-((S)-2-hydroxy-ethylcarbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl}-methyl)-carbamoyl]-ethyl}-3-(4-hydroxy-phenyl)-propionamide

2-Ala-4-MePhe-5-Gly-Enkephalin

2-Amino-N-{1-[({[1-(2-hydroxy-ethylcarbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl}-methyl)-carbamoyl]-ethyl}-3-(4-hydroxy-phenyl)-propionamide

[D-Ala2,N-Me-Phe,Gly-ol]enkephalin

[D-Ala2,NMe-Phe4,Gly-ol5]-enkephalin

[TYROSYL 3,5-3H]DAMGO

[tyrosyl-3,5-3H(N)]-D-Ala2-Mephe4-glyol5-enkephalin

A0A0H4AWC7_DUGDU

A0A0V1DID4_TRIBR

Cannabinoid receptor 1

DAGO

DAGOL

DAGOlyol

DAMGE

damgo tfa (78123-71-4(free base))

DAMGO;[D-ALA2,NME-PHE4,GLY-OL5]-ENKEPHALIN

F7A0F2_XENTR

glyol

H-Tyr-D-Ala-Gly-N(Me)Phe-Gly-ol

L-tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-Nα-methyl-L-phenylalaninamide

Neuropeptides B/W receptor type 1

Norepinephrine transporter

NPBW1_HUMAN

OPRD_HUMAN

OPRD_MOUSE

OPRD_PIG

OPRD_RAT

OPRK_CAVPO

OPRK_HUMAN

OPRK_RAT

OPRM_CAVPO

OPRM_HUMAN

OPRM_MOUSE

OPRM_RAT

Q9JIA2_RAT

SC6A4_RAT

Sodium-dependent serotonin transporter

Tyr-Ala-Gly-(NMe)Phe-Gly-ol

Δ-type opioid receptor

Δ-type/μ-type opioid receptor

κ-type opioid receptor

κ-type opioid receptor isoform 1

μ-type opioid receptor